Page last updated: 2024-08-25

nobiletin and Bone Loss, Perimenopausal

nobiletin has been researched along with Bone Loss, Perimenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, S; Hirata, M; Inada, M; Matsumoto, C; Miyaura, C; Takita, M; Tominari, T	1

Other Studies

1 other study(ies) available for nobiletin and Bone Loss, Perimenopausal

Article	Year
Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency. Journal of pharmacological sciences, 2011, Volume: 115, Issue:1 Topics: Animals; Bone Resorption; Cyclooxygenase 2; Depression, Chemical; Estrogens; Female; Flavones; Humans; Interleukin-1; Mice; NF-kappa B; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Prostaglandins E; Transcription, Genetic	2011

Article

Year

Nobiletin, a polymethoxy flavonoid, suppresses bone resorption by inhibiting NFκB-dependent prostaglandin E synthesis in osteoblasts and prevents bone loss due to estrogen deficiency.

Journal of pharmacological sciences, 2011, Volume: 115, Issue:1

Topics: Animals; Bone Resorption; Cyclooxygenase 2; Depression, Chemical; Estrogens; Female; Flavones; Humans; Interleukin-1; Mice; NF-kappa B; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Prostaglandins E; Transcription, Genetic

2011